There is growing research on the benefits of the weight loss drug liraglutide in treating other conditions such as sleep apnea in obese adults.
According to a study conducted by pharmaceutical company Eli Lilly, it was conducted through two trials, one of which used continuous positive airway pressure devices that prevent air from blowing into the airways during sleep.
According to information reported in the “Health Day” newspaper, after 52 weeks of using Gbound, the average number of incidents of device use was reduced by 6 cases among those taking Gbound. For those who took a placebo.
The manufacturer said in a statement Wednesday that it plans to share additional results from the study at the American Diabetes Association's annual meeting next June and submit the results to the Food and Drug Administration this summer.
Obstructive sleep apnea affects millions of people, yet 85% of cases go undiagnosed and therefore untreated.
If left untreated, sleep apnea can lead to irregular heartbeats, heart failure, and even death.
read more:
Courage and quick wit.. a woman saves her family from death
She suffered from these symptoms…a type of cancer that shockingly ended a woman's life
30 days before infection… Unexpected signs of a heart attack
He is two months old.. Police found a baby on the “railway tracks” – this is what happened to him.
4 astrological signs with bad luck in the coming days
